Xspray Pharma AB (publ) (STO:XSPRAY)

Sweden flag Sweden · Delayed Price · Currency is SEK
30.95
-1.95 (-5.93%)
Apr 15, 2025, 2:59 PM CET
-23.58%
Market Cap 1.22B
Revenue (ttm) n/a
Net Income (ttm) -285.52M
Shares Out 37.14M
EPS (ttm) -8.62
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 8,822
Average Volume 22,292
Open 32.95
Previous Close 32.90
Day's Range 30.60 - 33.00
52-Week Range 23.00 - 91.70
Beta 0.65
RSI 60.93
Earnings Date Mar 27, 2025

About Xspray Pharma AB

Xspray Pharma AB (publ), a pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden. The company’s product candidates include Dasynoc, a trailblazer, under approval phase for the treatment of chronic myeloid leukemia and acute lymphoblastic leukemia; XS003, an amorphous non-crystalline nilotinib, under pivotal studies for the treatment of chronic myeloid leukemia; XS008, based on axitinib, under development for treatment of kidney cancer; and XS00Y under development phase. It has p... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2003
Employees 27
Stock Exchange Nasdaq Stockholm
Ticker Symbol XSPRAY
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.